HEALTHWHRO HAMPTON ROADS
New pancreatic cancer drug program may help rural patients get treatment closer to home
A new pancreatic cancer drug program, Daraxonrasib, which is not fully FDA-approved, may help rural patients access treatment closer to home. Brad Dugai from Mathews County is one of the patients benefiting from this program.
Related Signal
Adjacent reporting
- WATCH: How a new drug could lengthen lives of pancreatic cancer patients
- FDA expands access to drug helping pancreatic cancer patients
- New drug offers possible breakthrough for some pancreatic cancer patients
- STAT+: For pancreatic cancer patients, an exciting drug can feel out of reach
- FDA expanding access to pancreatic cancer drug to some patients
- High hopes for new pancreatic cancer therapies